PATENT CLAIM ANALYSIS

Application Number: 15874768
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "211040"]

Abstract:
The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I): wherein R 1  represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R 2  and R 3  are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R 4  and R 5  are the same or different and each represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, R 6  represents a hydrogen atom or the like, each R 7  may be the same or different and may each represent an optionally substituted C1-6 alkoxy group or the like, X represents —CH═, —C(—R 7 )═, or —N═, and m represents 1 to 4, or a pharmacologically acceptable salt thereof.

Claim (Index 13):
The method of  claim 12 , wherein R 1  is hydrogen atom.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 2.60606
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15481151', '15142858', '14142479', '15112647', '12066813']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8212825630484422
- 35 USC 102 Novelty (BERT): 0.5370678152532942
- Combined Prediction Score: 0.7928610882689273
- Mean Citation Score: 333.586858
- Max Citation Score: 376.21213
- Similarity Product: 238.2891839502317

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test